Login Register Cart 0
Generic placeholder image

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5230
ISSN (Online): 1875-614X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Evaluation of the Role of Ghrelin and Leptin as Biochemical Markers in Female with Polycystic Ovarian Syndrome

Author(s): Mahmod Khalil Ibrahim and Amina Hamed Ahmed Alobaidi*

Volume 20, Issue 4, 2021

Published on: 22 April, 2021

Page: [373 - 379] Pages: 7

DOI: 10.2174/1871523020666210422132618

Price: $65

Abstract

Introduction: Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder in women of reproductive age. PCOS is a heterogeneous complex disorder of defined aetiology. Some studies report its association with various endocrine, metabolic and immunological abnormalities. The hunger hormones ghrelin and leptin affect the pathogenesis of PCOS and might lead to the development of Metabolic Syndrome (MS) in obese women.

Aim: The study aims at evaluating the role of ghrelin and leptin level in females with polycystic ovary syndrome as a biochemical marker for the diagnosis and monitoring progression.

Subjects and Methods: The study included one hundred PCOS patients and fifty apparently healthy subjects with regular menstrual cycle, visiting gynecology outpatient clinic of Kalar General Hospital, from the beginning of February 2015 to the end of June 2015. Body Mass Index (BMI) along with serum ghrelin, leptin, Luteinizing Hormone (LH), Follicle Stimulating Hormone (FSH) and testosterone levels were measured for both groups. Serum leptin was determined using sandwich ELISA, while serum ghrelin was determined using competitive ELISA. Differences between patient and control groups were assessed by using a t-test. Also, one-way Anova was used to test the relationships among different groups.

Results: A significant decrease in ghrelin level and an increase in leptin levels in women with PCOS were observed compared to the control group. Also, a significant elevation in serum levels of LH, Testosterone, Prolactin, and a decrease in serum FSH in PCOS patients were observed, when compared to the control group. Additionally, serum ghrelin decreased and serum leptin level increased significantly in women with PCOS compared to controls in all age and BMI groups.

Conclusion: A significant decrease in ghrelin and an increase in leptin in PCOS patients were observed than in controls, indicating that they are at high risk for metabolic syndrome development.

Keywords: Adiponectin, follicular stimulating hormone, luteinizing hormone, prolactin, testosterone, leptin

« Previous Next »
[1]
Baqer, L.S.; Alobaidi, A.H.A.; Ehmaed, M.S.; Alsamarai, A.G.M. Evaluation of the effect of Metformin on hormones serum levels in women with polycystic ovary syndrome. World J. Pharm. Pharm. Sci., 2015, 4(6), 1574-1581.
[2]
Mobeen, H.; Afzal, N.; Kashif, M. Polycystic ovary syndrome may be an autoimmune disorder. Scientifica, 2016, 16
[http://dx.doi.org/10.1155/2016/4071735]
[3]
De Leo, V.; Musacchio, M.C.; Cappelli, V.; Massaro, M.G.; Morgante, G.; Petraglia, F. Genetic, hormonal and metabolic aspects of PCOS: An update. Reprod. Biol. Endocrinol., 2016, 14(1), 38.
[http://dx.doi.org/10.1186/s12958-016-0173-x] [PMID: 27423183]
[4]
Alobaidi, A.H.A.; Abrahem, M.K.; Ahmad, S.S.; Alsamarai, A.G.M. Dyslipidemia and oxidative stress in Iraqi women with polycystic ovary syndrome. World J. Pharm. Pharm. Sci., 2015, 4(9), 39-48.
[5]
Mutharasan, P.; Galdones, E.; Peñalver Bernabé, B.; Garcia, O.A.; Jafari, N.; Shea, L.D.; Woodruff, T.K.; Legro, R.S.; Dunaif, A.; Urbanek, M. Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry. J. Clin. Endocrinol. Metab., 2013, 98(1), E185-E190.
[http://dx.doi.org/10.1210/jc.2012-2471] [PMID: 23118426]
[6]
Rosenfield, R.L. The diagnosis of polycystic ovary syndrome in adolescents. Pediatrics, 2015, 136(6), 1154-1165.
[http://dx.doi.org/10.1542/peds.2015-1430] [PMID: 26598450]
[7]
Al Khaduri, M.; Al Farsi, Y.; Al Najjar, T.A.; Gowri, V. Hospital-based prevalence of polycystic ovarian syndrome among Omani women. Middle East Fertil. Soc. J., 2014, 19(2), 135-138.
[http://dx.doi.org/10.1016/j.mefs.2013.06.006]
[8]
Ding, T.; Hardiman, P.J.; Petersen, I.; Wang, F.F.; Qu, F.; Baio, G. The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: A systematic review and meta-analysis. Oncotarget, 2017, 8(56), 96351-96358.
[http://dx.doi.org/10.18632/oncotarget.19180] [PMID: 29221211]
[9]
van der Lely, A.J.; Tschöp, M.; Heiman, M.L.; Ghigo, E. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr. Rev., 2004, 25(3), 426-457.
[http://dx.doi.org/10.1210/er.2002-0029] [PMID: 15180951]
[10]
Barash, I.A.; Cheung, C.C.; Weigle, D.S.; Ren, H.; Kabigting, E.B.; Kuijper, J.L.; Clifton, D.K.; Steiner, R.A. Leptin is a metabolic signal to the reproductive system. Endocrinology, 1996, 137(7), 3144-3147.
[http://dx.doi.org/10.1210/endo.137.7.8770941] [PMID: 8770941]
[11]
Barber, T.M.; Franks, S. Obesity and polycystic ovary syndrome. Clin. Endocrinol. (Oxf.), 2021.
[http://dx.doi.org/10.1111/cen.14421] [PMID: 33460482]
[12]
Kamal, M.; Mohi, A.; Fawzi, M.; El- Sawah, H. Fasting plasma ghrelin in women with and without PCOS. Middle East Fertil. Soc. J., 2010, 15, 91-94.
[http://dx.doi.org/10.1016/j.mefs.2010.04.006]
[13]
Houjeghani, S.; Pourghassem Gargari, B.; Farzadi, L. Serum leptin and ghrelin levels in women with polycystic ovary syndrome: correlation with anthropometric, metabolic, and endocrine parameters. Int. J. Fertil. Steril., 2012, 6(2), 117-126.
[PMID: 25493169]
[14]
Gao, T.; Wu, L.; Chang, F.; Cao, G. Low circulating ghrelin levels in women with polycystic ovary syndrome: A systematic review and meta-analysis. Endocr. J., 2016, 63(1), 93-100.
[http://dx.doi.org/10.1507/endocrj.EJ15-0318] [PMID: 26607017]
[15]
Hussein, A.A.; Baban, R.S.; Hussein, A.G. Ghrelin and insulin resistance in a sample of Iraqi women with polycystic ovary syndrome. Iraqi J. Med. Sci., 2014, 12(1), 51-59.
[16]
Garin, M.C.; Butts, S.F.; Sarwer, D.B.; Allison, K.C.; Senapati, S.; Dokras, A. Ghrelin is independently associated with anti-mullerian hormone levels in obese but not non-obese women with polycystic ovary syndrome. Endocrine, 2017, 55(3), 907-913.
[http://dx.doi.org/10.1007/s12020-016-1210-4] [PMID: 28004236]
[17]
Waśko, R.; Komarowska, H.; Warenik-Szymankiewicz, A.; Sowiński, J. Elevated ghrelin plasma levels in patients with polycystic ovary syndrome. Horm. Metab. Res., 2004, 36(3), 170-173.
[http://dx.doi.org/10.1055/s-2004-814341] [PMID: 15057670]
[18]
Daghestani, M.H.; Daghestani, M.; Daghistani, M.; El-Mazny, A.; Bjørklund, G.; Chirumbolo, S.; Al Saggaf, S.H.; Warsy, A. A study of ghrelin and leptin levels and their relationship to metabolic profiles in obese and lean Saudi women with polycystic ovary syndrome (PCOS). Lipids Health Dis., 2018, 17(1), 195.
[http://dx.doi.org/10.1186/s12944-018-0839-9] [PMID: 30131073]
[19]
Kale-Gurbuz, T.; Akhan, S.E.; Bastu, E.; Telci, A.; Iyibozkurt, A.C.; Topuz, S. Adiponectin, leptin and ghrelin levels in obese adolescent girls with polycystic ovary syndrome. J. Pediatr. Adolesc. Gynecol., 2013, 26(1), 27-30.
[http://dx.doi.org/10.1016/j.jpag.2012.09.002] [PMID: 23158749]
[20]
Dupont, J.; Maillard, V.; Coyral-Castel, S.; Ramé, C.; Froment, P. Ghrelin in female and male reproduction. Int. J. Pept., 2010, 2010, 158102.
[http://dx.doi.org/10.1155/2010/158102] [PMID: 20700403]
[21]
Koleva, D.I.; Orbetzova, M.M.; Atanassova, P.K. Adipose tissue hormones and appetite and body weight regulators in insulin resistance. Folia Med. (Plovdiv), 2013, 55(1), 25-32.
[http://dx.doi.org/10.2478/folmed-2013-0002] [PMID: 23905484]
[22]
Barber, T.M.; Casanueva, F.F.; Karpe, F.; Lage, M.; Franks, S.; McCarthy, M.I.; Wass, J.A. Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome. Eur. J. Endocrinol., 2008, 158(4), 511-516.
[http://dx.doi.org/10.1530/EJE-07-0683] [PMID: 18362298]
[23]
Barreiro, M.L.; Tena-Sempere, M. Ghrelin and reproduction: A novel signal linking energy status and fertility? Mol. Cell. Endocrinol., 2004, 226(1-2), 1-9.
[http://dx.doi.org/10.1016/j.mce.2004.07.015] [PMID: 15488999]
[24]
Pagotto, U.; Gambineri, A.; Vicennati, V.; Heiman, M.L.; Tschöp, M.; Pasquali, R. Plasma ghrelin, obesity, and the polycystic ovary syndrome: Correlation with insulin resistance and androgen levels. J. Clin. Endocrinol. Metab., 2002, 87(12), 5625-5629.
[http://dx.doi.org/10.1210/jc.2002-020776] [PMID: 12466363]
[25]
AL-Watify, DGO Abnormalities of hormones and inflammatory cytokines in women affected with polycystic ovary syndrome. J. Nat. Sci. Res, 2014, 4(6), 49-53.
[26]
Zheng, S.H.; Du, D.F.; Li, X.L. Leptin levels in women with polycystic ovary syndrome: A systematic review and meta-analysis. Reprod. Sci., 2017, 24(5), 656-670.
[http://dx.doi.org/10.1177/1933719116670265] [PMID: 27798245]
[27]
Nomair, A.M.; Aref, N.K.; Rizwan, F.; Ezzo, O.H.; Hassan, N. Serum leptin level in obese women with polycystic ovary syndrome, and its relation to insulin resistance. Asian Pac. J. Reprod., 2014, 3(4), 288-294.
[http://dx.doi.org/10.1016/S2305-0500(14)60041-5]
[28]
Ramanand, S.J.; Ramanand, J.B.; Jain, S.S.; Raparti, G.T.; Ghanghas, R.R.; Halasawadekar, N.R. Leptin in non PCOS and PCOS women: A comparative study. Int. J. Basic Clin. Pharmacol., 2014, 3(1), 186-193.
[http://dx.doi.org/10.5455/2319-2003.ijbcp20140224]
[29]
Pehlivanov, B.; Mitkov, M. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome. Eur. J. Contracept. Reprod. Health Care, 2009, 14(2), 153-159.
[http://dx.doi.org/10.1080/13625180802549962] [PMID: 19340711]
[30]
Olszanecka-Glinianowicz, M.; Madej, P.; Nylec, M.; Owczarek, A.; Szanecki, W.; Skałba, P.; Chudek, J. Circulating apelin level in relation to nutritional status in polycystic ovary syndrome and its association with metabolic and hormonal disturbances. Clin. Endocrinol. (Oxf.), 2013, 79(2), 238-242.
[http://dx.doi.org/10.1111/cen.12120] [PMID: 23199261]
[31]
Jahromi, B.N.; Dabaghmanedsh, M.H.; Parsanezhad, M.E.; Fatehpoor, F. Association of leptin and insulin resistance in PCOS: A case-control study. Int. J. Reprod. Biomed. (Yazd), 2017, 15, 423-428.
[http://dx.doi.org/10.29252/ijrm.15.7.423]
[32]
Marx, T.L.; Mehta, A.E. Polycystic ovary syndrome: pathogenesis and treatment over the short and long term. Cleve. Clin. J. Med., 2003, 70(1), 31-33, 36-41, 45.
[http://dx.doi.org/10.3949/ccjm.70.1.31] [PMID: 12549723]
[33]
El-Gharib, M.N.; Badawy, T.E. Correlation between insulin, leptin and polycystic ovary syndrome. J. Basic Clin. Reprod. Sci., , 2014, 3, 49-53.
[http://dx.doi.org/10.4103/2278-960X.129281]
[34]
Azziz, R.; Carmina, E.; Dewailly, D.; Diamanti-Kandarakis, E.; Escobar-Morreale, H.F.; Futterweit, W.; Janssen, O.E.; Legro, R.S.; Norman, R.J.; Taylor, A.E.; Witchel, S.F. Task force on the phenotype of the polycystic ovary syndrome of the androgen excess and PCOS society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: The complete task force report. Fertil. Steril, 2009, 91(2), 456-488.
[http://dx.doi.org/10.1016/j.fertnstert.2008.06.035] [PMID: 18950759]
[35]
Fakhoury, H.; Tamim, H.; Ferwana, M.; Siddiqui, I.A.; Adham, M.; Tamimi, W. Age and BMI adjusted comparison of reproductive hormones in PCOS. J. Family Med. Prim. Care, 2012, 1(2), 132-136.
[http://dx.doi.org/10.4103/2249-4863.104984] [PMID: 24479022]
[36]
Kanwar, G.; Jain, N.; Shekawat, M.; Sharma, N. Estimation of LH, FSH, prolactin and TSH levels in polycystic ovarian syndrome and correlation of LH and FSH with serum TSH levels. IOSR J. Dental Med. Sci., 2015, 14(5), 64-68.
[37]
Akram, M.; Roohi, N. Endocrine correlates of polycystic ovary syndrome in Pakistani women. J. Coll. Physicians Surg. Pak., 2015, 25(1), 22-26.
[PMID: 25604364]
[38]
Kumar, A.N.; Naidu, J.N.; Satyanarayana, U.; Ramalingam, K.; Anitha, M. Metabolic and endocrine characteristics of Indian women with polycystic ovary syndrome. Int. J. Fertil. Steril., 2016, 10(1), 22-28.
[PMID: 27123196]
[39]
Hernandez, E.R.; Resnick, C.E.; Holtzclaw, W.D.; Payne, D.W.; Adashi, E.Y. Insulin as a regulator of androgen biosynthesis by cultured rat ovarian cells: Cellular mechanism(s) underlying physiological and pharmacological hormonal actions. Endocrinology, 1988, 122(5), 2034-2043.
[http://dx.doi.org/10.1210/endo-122-5-2034] [PMID: 3282873]
[40]
Nahum, R.; Thong, K.J.; Hillier, S.G. Metabolic regulation of androgen production by human thecal cells in vitro. Hum. Reprod., 1995, 10(1), 75-81.
[http://dx.doi.org/10.1093/humrep/10.1.75] [PMID: 7745074]
[41]
Nestler, J.E.; Clore, J.N.; Blackard, W.G. The central role of obesity (hyperinsulinemia) in the pathogenesis of the polycystic ovary syndrome. Am. J. Obstet. Gynecol., 1989, 161(5), 1095-1097.
[http://dx.doi.org/10.1016/0002-9378(89)90640-6] [PMID: 2686438]

Rights & Permissions Print Cite
Article Metrics
18
2
© 2024 Bentham Science Publishers | Privacy Policy